SCHEMBL6090219

SCHEMBL6090219

CCOC(=O)c1c(-c2ccccc2)c2cc(-c3cccnc3)ccc2n1CCCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.54
MAPK8 P45983 2/20 0.45
NR4A2 P43354 1/20 0.44
MMP2 P08253 1/20 0.43
MMP13 P45452 1/20 0.43
MMP14 P50281 1/20 0.43
TBXAS1 P24557 3/20 0.42
PAX8 Q06710 1/20 0.42
S1PR3 Q99500 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ACHE P22303 2/20 0.41
PLA2G2A P14555 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
PTGER4 P35408 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6091187 0.88 SERPINE1 (0.44) MAPK8NR4A2TBXAS1PLA2G2AKDM4E
SCHEMBL6090931 0.83 KMT2A (0.58) KMT2AMAPK8PLA2G2AKDM4EMAPT
SCHEMBL5746891 0.79 KMT2A (0.52) KMT2AMAPK8PLA2G2AKDM4EMAPT
SCHEMBL11263827 0.71 KMT2A (0.60) KMT2APLA2G2ASMN1; SMN2
SCHEMBL4886339 0.71 PLA2G2A (0.55) KMT2AMAPK8S1PR3PLA2G2AKDM4E
SCHEMBL11729659 0.70 KMT2A (0.56) KMT2AMAPK8KDM4EMAPTCYP1A2
SCHEMBL15074529 0.70 MAPT (0.59) KMT2ATBXAS1NPC1RAB9AL3MBTL1
SCHEMBL25761874 0.70 TBXAS1 (0.45) KMT2ATBXAS1S1PR3PLA2G2AGABRA1
SCHEMBL4893009 0.69 PLA2G2A (0.51) KMT2AMAPK8PLA2G2AKDM4EMAPT
SCHEMBL5739485 0.69 ACLY (0.53) KMT2AMAPK8MAPTCYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160879-A1 Indoles useful in the treatment of inflammation BIOLIPOX AB (SE) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160879-A1 Indoles useful in the treatment of inflammation IDO1, PTGS1, IDO2 KMT2A 3542/4885MAPK8 3463/4885NR4A2 1637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.